Bioscience Animal Health PCL (BKK:BIS) Total Equity: ฿816 Mil (As of Mar. 2026)


BKK:BIS Bioscience Animal Health PCL BKK:BIS
81 GF Score
Price ฿2.06
GF Value ฿2.87
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Bioscience Animal Health PCL Total Equity?

Bioscience Animal Health PCL BKK:BIS +0.98% 81 Total Equity is ฿816 Mil as of Mar. 2026. GuruFocus rates BKK:BIS with a GF Score™ of 81/100 and a GF Value™ of ฿2.87 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Bioscience Animal Health PCL's total equity for the quarter that ended in Mar. 2026 was ฿816 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioscience Animal Health PCL Total Equity Historical Data

* Premium members only.

The historical data trend for Bioscience Animal Health PCL's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioscience Animal Health PCL Total Equity Chart

Bioscience Animal Health PCL Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only 266.82 768.55 790.50 813.73 798.05

Bioscience Animal Health PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 833.61 824.00 810.31 798.05 815.75
BKK:BIS
81GF Score
Bioscience Animal Health PCL BKK:BIS
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioscience Animal Health PCL Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioscience Animal Health PCL's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1257.826-459.772
=798

Bioscience Animal Health PCL's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1203.825-388.077
=816

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ฿816 Mil mean?
Bioscience Animal Health PCL (BKK:BIS) has a Total Equity of ฿816 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Bioscience Animal Health PCL and its competitors.
Is Bioscience Animal Health PCL's Total Equity too high?
Bioscience Animal Health PCL's current Total Equity is ฿816 Mil. Overall, Bioscience Animal Health PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's Total Equity compare to KHC and GIS?
Bioscience Animal Health PCL's Total Equity of ฿816 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bioscience Animal Health PCL and its competitors. Bioscience Animal Health PCL's current Total Equity is ฿816 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.87, compared to a current price of ฿2.06 — trading 28.2% below its estimated fair value. The current Total Equity is ฿816 Mil. Bioscience Animal Health PCL's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current Total Equity is ฿816 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?

Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued. The current stock price of ฿2.06 is trading 28.2% below its estimated GF Value™ of ฿2.87. GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.

Key valuation signals for BKK:BIS:

  • Total Equity: ฿816 Mil
  • GF Value™: ฿2.87 vs. price of ฿2.06 (28.2% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioscience Animal Health PCL Business Description

Address Bond Street Road, No. 479, 4th Floor, Muangthongthani, Bangphut, Pakkret, Nonthaburi, THA, 11120
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
81GF Score

Get the complete analysis for BKK:BIS

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.06
Price
฿2.87
GF Value